Self-propelled Janus micromotors for pH-responsive release of small molecule drug
Source abstract
Abstract
Oral administration of drugs has received significant attention in the last 1, 2 decades, as it is the most comfortable and painless administration route, which leads to high patient compliance. Although oral delivery of drugs shows positive effects in patients, several hurdles must be overcome such as enzymatic degradation, large pH-variations found throughout the gastrointestinal (GI) tract, and continuous mucus secretion. We have studied biocompatible non-toxic micromotors as promising man-made microdevices for targeted furosemide release. Micromotors are micro-scale autonomous entities that can perform various tasks in the GI tract as a result of their impressive motion abilities. Their directional motion makes them ideal candidates to bring the necessary drug dosage to where it is needed. Herein, the micromotors were loaded for the first time with furosemide and coated with pH-sensitive polymer Eudragit® L100 using ultrasonic spray coating technique in order to achieve targeted drug delivery and pH-responsive release. Coherent anti-Stokes Raman scattering spectroscopy (CARS) was used for visualizing drug loading efficiency on the surface of micromotors. In vitro drug release was evaluated under acidic and neutral pH chemical environments and obtained results confirm their function as pH-sensitive microdevices for a drug release.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Micro and Nano Robotics · Microfluidic and Bio-sensing Technologies · Pickering emulsions and particle stabilization
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (50)
Show source-provided references
1. Oral insulin delivery by means of solid lipid nanoparticles
2. Nanostructured lipid carriers: versatile oral delivery vehicle10.1016/j.colsurfb.2017.11.064 ↗
3. The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection10.1586/14787210.2014.930663 ↗
4. Self-emulsifying drug delivery system: Mucus permeation and innovative quantification technologies10.1016/j.addr.2019.04.001 ↗
5. Nanoemulsions coated with alginate/chitosan as oral insulin delivery systems: preparation, characterization, and hypoglycemic effect in rats
6. Polymeric nanocapsules with SEDDS oil-core for the controlled and enhanced oral absorption of cyclosporine10.1016/j.ijpharm.2012.10.018 ↗
7. Oral drug absorption: Evaluation and prediction
8. Peroral route: An opportunity for protein and peptide drug delivery10.1021/cr000700m ↗
9. Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers10.1016/j.addr.2011.12.009 ↗
10. Nanocarriers for oral drug delivery10.3109/1061186X.2013.789033 ↗
11. Light/gas cascade-propelled Janus micromotors that actively overcome sequential and multi-staged biological barriers for precise drug delivery10.1016/j.cej.2020.127897 ↗
12. Nano/micromotors for diagnosis and therapy of cancer and infectious diseases10.1002/chem.201903475 ↗
13. Micro/nanorobots for biomedicine: delivery, surgery, sensing, and detoxification10.1126/scirobotics.aam6431 ↗
14. Magnesium-based micromotors: Water-powered propulsion, multifunctionality, and biomedical and environmental applications
15. Designable dual-power micromotors fabricated from a biocompatible gas-shearing strategy10.1016/j.cej.2020.127187 ↗
16. Magnesium-based micromotors as hydrogen generators for precise rheumatoid arthritis therapy10.1021/acs.nanolett.0c04438 ↗
17. Light-driven micromotors to dissociate protein aggregates that cause neurodegenerative diseases
18. Artificial micromotors in the mouse’s stomach: A step toward in vivo use of synthetic motors10.1021/nn507097k ↗
19. Microrobots derived from variety plant pollen grains for efficient environmental clean up and as an anti-cancer drug carrier10.1002/adfm.202000112 ↗
20. Micromotor-enabled active drug delivery for in vivo treatment of stomach infection
21. Biopsy with thermally-responsive untethered microtools10.1002/adma.201203348 ↗
22. Targeting 3D bladder cancer spheroids with urease-powered nanomotors10.1021/acsnano.8b06610 ↗
23. Self-propelled affinity biosensors: Moving the receptor around the sample10.1016/j.bios.2015.04.095 ↗
24. Multifunctional biohybrid magnetite microrobots for imaging-guided therapy10.1126/scirobotics.aaq1155 ↗
25. Micromachine-enabled capture and isolation of cancer cells in complex media10.1002/ange.201100115 ↗
26. Fully loaded micromotors for combinatorial delivery and autonomous release of cargoes10.1002/smll.201303646 ↗
27. Enzymatic/magnetic hybrid micromotors for synergistic anticancer therapy10.1021/acsami.1c07593 ↗
28. MOF-derived magnetic Co@porous carbon as a direction-controlled micromotor for drug delivery10.1039/D0NJ04957C ↗
29. Enteric micromotor can selectively position and spontaneously propel in the gastrointestinal tract10.1021/acsnano.6b04795 ↗
30. Furosemide (frusemide) a pharmacokinetic/pharmacodynamic review (part I)10.2165/00003088-199018050-00004 ↗
31. Polymeric microcontainers improve oral bioavailability of furosemide10.1016/j.ijpharm.2016.03.050 ↗
32. Biowaiver monographs for immediate release solid oral dosage forms: Furosemide10.1002/jps.22030 ↗
33. Study on electrochemically deposited Mg metal10.1016/j.jpowsour.2010.11.141 ↗
34. Process optimization of ultrasonic spray coating of polymer films10.1021/la4010246 ↗
35. Magnesium: nutrition and metabolism10.1016/S0098-2997(02)00089-4 ↗
36. Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin10.1021/ja908117a ↗
37. Influence of an enteric polymer on drug release rates of theophylline from pellets coated with Eudragit® RS 30D10.1081/PDT-120017529 ↗
38. Self-propelled autonomous Mg/Pt Janus micromotor interaction with human cells10.1246/bcsj.20190104 ↗
39. Magnesium-based micromotors: Water-powered propulsion, multifunctionality, and biomedical and environmental applications
40. Seawater-driven magnesium based Janus micromotors for environmental remediation10.1039/c3nr01458d ↗
41. Furosemide in patients with heart failure: Shift in dose-response curves10.1038/clpt.1980.148 ↗
42. Self-propelled micromotors driven by the magnesium–water reaction and their hemolytic properties10.1002/anie.201300913 ↗
43. Autonomous motion and temperature-controlled drug delivery of Mg/Pt-Poly(N-isopropylacrylamide) Janus micromotors driven by simulated body fluid and Blood Plasma10.1021/am502729y ↗
44. Self-propelled PLGA micromotor with chemotactic response to inflammation10.1002/adhm.201901710 ↗
45. Perspectives on Janus micromotors: Materials and applications10.1016/j.apmt.2017.09.005 ↗
46. Autonomous motion and temperature-controlled drug delivery of Mg/Pt-poly(n -isopropylacrylamide) janus micromotors driven by simulated body fluid and blood plasma10.1021/am502729y ↗
47. Self-propelled manganese oxide-based catalytic micromotors for drug delivery10.1039/C6RA13739C ↗
48. Reynolds numbers influence the directionality of self-propelled microjet engines in the 10-4 regime10.1039/c3nr01891a ↗
49. Self-propelled micromotors driven by the magnesium–water reaction and their hemolytic properties10.1002/anie.201300913 ↗
50. From concept to in vivo testing: Microcontainers for oral drug delivery10.1016/j.jconrel.2017.10.013 ↗